Katharina Seystahl
Overview
Explore the profile of Katharina Seystahl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
558
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stadler C, Gramatzki D, Le Rhun E, Hottinger A, Hundsberger T, Roelcke U, et al.
Neurooncol Pract
. 2024 Mar;
11(2):132-141.
PMID: 38496908
Background: Incidence rates of glioblastoma in very old patients are rising. The standard of care for this cohort is only partially defined and survival remains poor. The aims of this...
2.
Le Rhun E, Devos P, Seystahl K, Jongen J, Gramatzki D, Roth P, et al.
Neurology
. 2024 Feb;
102(5):e207959.
PMID: 38335471
Background And Objectives: Hydrocephalus is a common radiologic sign in patients with leptomeningeal metastasis (LM) from solid tumors which can be assessed using the Evans index (EI). Here, we explored...
3.
Mastall M, Roth P, Bink A, Maranta A, Laubli H, Hottinger A, et al.
BMC Cancer
. 2024 Jan;
24(1):82.
PMID: 38225589
Background: Glioblastoma is the most common and most aggressive malignant primary brain tumor in adults. Glioblastoma cells synthesize and secrete large quantities of the excitatory neurotransmitter glutamate, driving epilepsy, neuronal...
4.
Seystahl K, Martinez-Majander N, Salerno A, Beyeler M, Erdur H, Marto J, et al.
Neurology
. 2023 Jul;
101(12):e1241-e1255.
PMID: 37463747
Background And Objectives: IV thrombolysis (IVT) for suspected ischemic stroke in patients with intracranial neoplasms is off-label. However, data on risks of intracranial hemorrhage (ICH) are scarce. Methods: In a...
5.
Seystahl K, Schweizer J, Katan M, Weber S, Hug A, Wanner M, et al.
Neurooncol Pract
. 2023 Mar;
10(2):176-185.
PMID: 36970172
Background: Cancer in stroke patients is associated with higher levels of inflammatory biomarkers and unfavorable poststroke outcomes. We thus explored whether there is a link between cancer and stroke-associated infections....
6.
Seystahl K, Gramatzki D, Wanner M, Weber S, Hug A, Luft A, et al.
Sci Rep
. 2023 Jan;
13(1):111.
PMID: 36596831
It remains controversial which characteristics may predict occult cancer in stroke patients. Characteristics of patients with ischemic stroke registered in the Zurich Swiss Stroke Registry (2014 to 2016) were tested...
7.
Seystahl K, Oppong F, Le Rhun E, Hertler C, Stupp R, Nabors B, et al.
Neurooncol Adv
. 2022 Aug;
4(1):vdac112.
PMID: 35950086
Background: Levetiracetam (LEV) is one of the most frequently used antiepileptic drugs (AED) for brain tumor patients with seizures. We hypothesized that toxicity of LEV and temozolomide-based chemoradiotherapy may overlap....
8.
Hertler C, Seystahl K, Le Rhun E, Wirsching H, Roth P, Weller M, et al.
Neuro Oncol
. 2022 Jul;
24(11):2001-2004.
PMID: 35906902
No abstract available.
9.
Eisele A, Seystahl K, Rushing E, Roth P, Le Rhun E, Weller M, et al.
Eur J Neurol
. 2022 May;
29(8):2386-2397.
PMID: 35545894
Background And Purpose: Venous thromboembolic events (VTEs) are a major complication in cancer patients, and therefore, also in brain cancer patients, anticoagulants are considered appropriate in the treatment of VTEs....
10.
Stumpo V, Sebok M, van Niftrik C, Seystahl K, Hainc N, Kulcsar Z, et al.
MAGMA
. 2021 Dec;
35(1):29-44.
PMID: 34874499
Objectives: Innovative physiologic MRI development focuses on depiction of heterogenous vascular and metabolic features in glioblastoma. For this feasibility study, we employed blood oxygenation level-dependent (BOLD) MRI with standardized and...